GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Antares Pharma, Inc. (ATRS) [hlAlert]

Rating:
Outperform
ATRS
up 5.84 %

Antares Pharma, Inc. (ATRS) rated Outperform with price target $6 by Oppenheimer

Posted on: Friday,  Jun 21, 2013  8:25 AM ET by Oppenheimer

Oppenheimer rated Outperform Antares Pharma, Inc. (NASDAQ: ATRS) on 06/21/2013. Previously Oppenheimer rated Outperform Antares Pharma, Inc. (NASDAQ: ATRS) on 05/24/2011.,
when the stock price was $1.71. Since then, Antares Pharma, Inc. has gained 5.85% as of 01/25/2016's recent price of $1.81.
If you would have followed the previous Oppenheimer's recommendation on ATRS, you would have gained 5.84% of your investment in 1707 days.

Antares Pharma, Inc. (Antares) is a product development and pipeline company with drug delivery platforms, including Advanced Transdermal Delivery (ATD) gels, disposable pressure assisted auto injection systems (Vibex), reusable needle-free injection systems (VISION), disposable pen injection systems and oral disintegrating (Easy Tec) tablets. Two of these platforms have generated United States Food and Drug Administration (FDA) approved products. The Company develops, produces and markets pharmaceutical delivery products, including transdermal gels, oral disintegrating tablets and reusable needle-free and disposable pressure assisted auto injector and pen injector systems. The Company has operating facilities in the United States and Switzerland. Its United States operation manufactures and markets reusable needle-free injection devices and related disposables, and develops disposable pressure assisted auto injector and pen injector systems.

OppenheimerFunds, Inc. has been helping investors achieve their financial goals since 1960. We are one of the nation's largest and most respected asset management companies. At OppenheimerFunds, we believe that in order for you to reach your financial goals, your investments must perform. That is why investment excellence—over the long term and across the range of our products—is our highest priority. OppenheimerFunds and its controlled affiliates offer a broad range of products and services to individuals, corporations and institutions, including mutual funds, separately managed accounts, investment management for institutions, hedge fund products, qualified retirement plans and subadvisory investment-management services.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/21/2013 8:25 AM Buy
None
4.11 6.00
as of 12/13/2013
1 Week down  -0.50 %
1 Month up  5.89 %
3 Months down  -9.81 %
1 YTD up  3.67 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/24/2011 8:25 AM Buy
None
1.71 3.20

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy